Pediatric hyperfibrotic myelodysplasia: An unusual clinicopathologic entity

Pediatric Hematology and Oncology

Volumn 14, Issue 2, 1997, Pages 133-139

  Sahu, Satyajit ^a,b   Shah, Samir S ^a   Srivastava, Alok ^a   Dennison, David ^a   Chandy, Mammen ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

hyperfibrotic; myelodysplasia; pediatric

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD CHEMISTRY; BLOOD SMEAR; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; SCHOOL CHILD;

EID: 0030939606     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019709030899     Document Type: Article

References (22)

1. Weinstein IM. Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev. 1991;5:89-104.
2. Bouroncle BA, Doan CA. Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Am J Med Sci 1962;243:697-715.
3. Gadner H, Haas OA. Experience in pediatric myelodysplastic syndrome. Hematol Oncol Clin North Am. 1992;6:655-672.
4. Lambertenghi-Delihers G, Orazi A, Luksch R, et al. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinicopathological entity. Br J Haematol. 1991;78:161-166.
5. Manoharan A, Horselay R, Pitney WR. The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol. 1979;43:185-190.
6. Chessels JM. Myelodysplasia. Ballieres Clin Haematol. 1991;4:459.
7. McCarthy DM. Annotation: fibrosis of the bone marrow: content and cause. Br J Haematol. 1985; 59:1-7.
8. Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ. Myelofibrosis in primary myelodysplastic syndromes: a clinicomorphologic study of 10 cases. Br J Haematol. 1989;71:499-504.
9. Passamore SJ, Hann IM, Stiller CA, Ramani P, Chesselles JM. Paediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood. 1995;85:1742-1750.
10. Ian HM. Myelodysplastic syndromes. Arch Dis Child. 1992;62:962-966.
11. Creutzig U, Rajnoldi C, Ritter J, et al. Myelodysplastic syndromes in childhood. Am J Pediatr Hematol Oncol. 1987;9:324-330.
12. Bennett JM, Catovosky D, Daniel MT, et al. The French-American-British (FAB) co-operative group (1982) proposals for classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:185-199.
13. Den Ottolander GJ, Te Velde J, Brederoo J, Geraedts JPM. Megakaryoblastic leukaemia (acute myelofibrosis): a report of 3 cases. Br J Haematol. 1979;42:9-20.
14. Tricot G, de Wolf-Peeters C, Vlietinck P, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol. 1984;58:217.
15. Watts EJ, Majer RV, Green PJ, Mavor WO. Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone. Br J Haematol. 1991;78: 120-134.
16. Estevz JM, Urueta EE, Moran TJ. Acute megakaryocytic myelofibrosis. Case report of an unusual myeloproliferative syndrome. Am J Clin Pathol. 1974;62:52-58.
17. Bernabei PA, Arcangeli A, Casini M, Grossi A, Padovani R. Platelet derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. Br J Haematol. 1986;63:353-357.
18. Thiele J, Romatowski C, Wagner S, et al. Macrophages (phagocytic-histiocytic reticular cells) in reactive-inflammatory lesions of the bone marrow and in myelodysplastic syndromes (MDS). An immunohistochemical and morphometric study by use of a new monoclonal antibody (PG-M1). Pathol Res Pract. 1992;188:995-1001.
19. Lewis CM, Pegrum GD. Immune complexes in myelofibrosis: a possible guide to management. Br J Haematol. 1978;39:233.
20. Giorgio LD, Attilio O, Robert L, Claudio A, Davide S. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol. 1991;78:161-166.
21. Verhoef GE, De Wolf-Peeters C, Ferrant A, et al. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol. 1991;63:235-241.
22. Wolf BC, Neiman RS. Bone marrow in myeloproliferative and dysmyelopoietic syndromes. Hematol Oncol Clin North Am. 1988;2:669-694.